New COVID Local Risk Index Helps Cities Identify Neighborhoods at Highest Risk for COVID and Better Target Resources to Blunt Local Pandemic Impact

A new city-oriented COVID Local Risk Index will help municipal leaders identify cities and neighborhoods with populations at higher risk of COVID-19 infection and more severe COVID-19 illness by incorporating key risk factors of race and ethnicity, age, household crowding, poverty and underlying health conditions like diabetes and obesity.

Read more

NYU Langone Among First to Enroll Patients In Clinical Trial for COVID-19 Monoclonal Antibody Treatment

The first patients were treated as part of a clinical trial testing whether an antibody therapy can safely reduce COVID-19 disease severity. The experimental treatment consists of identical copies of an antibody, a blood protein related to those that occur naturally as part of the human immune system, researchers say.

Read more

Health System in Pandemic Epicenter Identifies Outcomes and New Risk Factors of Patients Hospitalized with COVID-19

A team of investigators at NYU Langone Health determined that just over half of 5,279 patients who tested positive for COVID-19 were hospitalized — and nearly a quarter of those hospitalized died or were discharged to hospice, including 60 percent who required ventilators.

Read more